Clinical and Molecular Characteristics of X-linked Agammaglobulinemia Patients 55 Years or Older

By afschroeder • June 27, 2025

Chin AT, Ochs HD, Kobayashi R, Abolhassani H, Alachkar H, Barmettler S, Baxendale H, Boiling K, Cantanzaro J, Chua I, Coulter T, Cunningham-Rundles C, Elcombe SE, Fischer A, Grimbacher B, Gupta S, Herriot R, Herwadkar A, Imai K, Inoue S, Kirkpatrick C, Knutsen AP, Kumararatne D, Lea E, Lin MW, Litzman J, Mahlaoui N, Moriya K, Nonoyama S, Patel S, Perez E, Quinti I, Hostoffer RW, Rothenfusser S, Sargur R, Shields A, Sogkas G, Suan D, Tan T, Thomas M, Warnatz K, Younger EM, Kuo CY. Clinical and Molecular Characteristics of X-linked Agammaglobulinemia Patients 55 Years or Older. J Allergy Clin Immunol Pract. 2025 Jun 24:S2213-2198(25)00606-3. doi: 10.1016/j.jaip.2025.06.025. Epub ahead of print. PMID: 40571245.

Tags: agammaglobulinemia, antibody deficiency, Bruton Tyrosine Kinase (BTK), Clinical Informatics, Fellow, General Internal Medicine, inborn error of immunity (IEI), Publications, X-linked agammaglobulinemia (XLA)

Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right Atrial Rupture

Makaroff KE, Hampilos K, Sayed S, Emert B, Hu X, Nsair A, Kwon M, Middlekauff H. Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right[...]

Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals

Tian J, Azhir A, Decaro M, Chau N, Hügel J, Morris M, Cheng J, Fard P, Bassett IV, Bell DS, Bernstam EV, Visweswaran S, Klann[...]

Use of Evidence-Based Type 2 Diabetes Preventive Therapies and Rates of Progression to Diabetes Among Veterans with Prediabetes by Race and Ethnicity, 2010-2019

Ly DP, Washington DL, Shekelle PG, Lee ML, Moin T. Use of Evidence-Based Type 2 Diabetes Preventive Therapies and Rates of Progression to Diabetes Among[...]